Sichuan Kelun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Sichuan Kelun Pharmaceutical Co Ltd cash flow reinvestment rate. Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting CN¥393.58 Million (capex CN¥393.58 Million ) from operating cash flow of CN¥537.31 Million. See Sichuan Kelun Pharmaceutical Co Ltd (002422) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Cash flow reinvestment rate of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. Historical reinvestment intensity for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. Explore 002422 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Sichuan Kelun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
Sichuan Kelun Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Sichuan Kelun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002422 cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥1.94 Billion | CN¥2.64 Billion | CN¥1.62 Billion | ▲ +84.5% |
| 2024 | 0.40x | CN¥1.78 Billion | CN¥4.49 Billion | CN¥1.68 Billion | ▼ -58.8% |
| 2023 | 0.96x | CN¥5.14 Billion | CN¥5.34 Billion | CN¥1.77 Billion | ▲ +71.8% |
| 2022 | 0.56x | CN¥1.75 Billion | CN¥3.13 Billion | CN¥896.02 Million | ▲ +1.7% |
| 2021 | 0.55x | CN¥1.57 Billion | CN¥2.85 Billion | CN¥990.56 Million | ▼ -24.1% |
| 2020 | 0.73x | CN¥1.61 Billion | CN¥2.22 Billion | CN¥1.23 Billion | ▼ -2.4% |
| 2019 | 0.74x | CN¥1.65 Billion | CN¥2.22 Billion | CN¥1.33 Billion | ▲ +34.5% |
| 2018 | 0.55x | CN¥1.63 Billion | CN¥2.95 Billion | CN¥1.33 Billion | ▼ -71.7% |
| 2017 | 1.95x | CN¥2.35 Billion | CN¥1.20 Billion | CN¥1.48 Billion | ▲ +86.4% |
| 2016 | 1.05x | CN¥1.81 Billion | CN¥1.73 Billion | CN¥1.37 Billion | ▼ -40.4% |
| 2015 | 1.76x | CN¥2.18 Billion | CN¥1.24 Billion | CN¥1.84 Billion | ▼ -22.3% |
| 2014 | 2.26x | CN¥2.76 Billion | CN¥1.22 Billion | CN¥2.76 Billion | ▲ +5.2% |
| 2013 | 2.15x | CN¥2.26 Billion | CN¥1.05 Billion | CN¥2.26 Billion | ▼ -68.8% |
| 2012 | 6.89x | CN¥2.77 Billion | CN¥402.77 Million | CN¥2.77 Billion | ▲ +17.8% |
| 2011 | 5.85x | CN¥2.00 Billion | CN¥342.93 Million | CN¥2.00 Billion | ▲ +34.8% |
| 2010 | 4.34x | CN¥647.22 Million | CN¥149.29 Million | CN¥647.22 Million | ▲ +294.8% |
| 2009 | 1.10x | CN¥275.29 Million | CN¥250.69 Million | CN¥275.29 Million | ▲ +7.1% |
| 2008 | 1.02x | CN¥226.58 Million | CN¥221.08 Million | CN¥226.58 Million | ▼ -1.4% |
| 2007 | 1.04x | CN¥175.05 Million | CN¥168.42 Million | CN¥175.05 Million | — |